Valpromide

DB04165InvestigationalSmall molecule

Valpromide is a valproic acid derivative used to treat epilepsy and as adjunct therapy for psychomotor agitation, depression, and manic episodes of bipolar disorder.

Formula / weight: C₈H₁₇NO · 143.2267 g/mol (avg)

Resolves to

Compound

UNIIRUA6CWU76GChEMBLCHEMBL93836ChEBI74562PubChem71113

Clinical / RWD

RxNorm23420ATCN03AG02

Structure

InChIKeyOMOMUFTZPTXCHP-UHFFFAOYSA-NSMILESCCCC(CCC)C(N)=O

Targets

Q9ZAG3limA

What you can answer from here — as of September 13, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

809Drug interactionsStructured to mechanism, not free text

18Structured indicationsCondition, population, route and combination as fields, not prose

14ContraindicationsEach with its own population and attribute set

3Marketed productsAcross 1 country and 1 labeller

1ATC codeIncluding every combination product, plus 11 drug categories

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Valpromide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account